Clinical trial

A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)

NCT00152191

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1996-10-01

PhasePHASE3

Study timeline

Study start (unknown)1996-10-01Date precision: month

Registry last updated2011-07-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

UFT (uracil, tegafur)DRUG

cyclophosphamide, methotrexate, and fluorouracilDRUG

Sponsors & collaborators

Taiho Pharmaceutical Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00152191 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.